Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, Precipio said it had amended and restated an earlier securities purchase agreement with investors. The amendment enables it to issue up to $1.3 million of additional notes with applicable warrants on substantially the same terms and conditions as the notes and warrants granted in connection with the prior securities purchase agreement. Investors can purchase the additional notes and warrants until Dec. 31, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

Newsweek discusses the privacy issues raised by digital medicine.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.